The Significance of MicroRNA-449a and Its Potential Target HDAC1 in Patients With Colorectal Cancer.
By: Daichi Ishikawa, Chie Takasu, Hideya Kashihara, Masaaki Nishi, Takuya Tokunaga, Jun Higashijima, Kozo Yoshikawa, Koji Yasutomo, Mitsuo Shimada

Department of Surgery, The University of Tokushima, Tokushima, Japan daichi-19850125@hotmail.co.jp.
2019-01-21; doi: 10.21873/anticanres.13414
Abstract

Background

In a previous study, we demonstrated that deficiency of microRNA-449a (miR-449a) promoted colorectal tumorigenesis. In this study, the significance of miR-449a in the prognosis and relationship with HDAC1 in colorectal cancer was examined.

Materials

Seventy-two patients with colorectal cancer and 16 patients with colorectal liver metastasis who underwent surgery were included. miR-449a expression in tumor tissue of resected specimen was investigated by real-time polymerase chain reaction and histone deacetylase 1 (HDAC1) expression was examined by immunohistochemistry.

Results

Lymphovascular invasion and increased serum carcinoembryonic antigen levels were seen more frequent in patients with low miR-449a expression. Patients with low miR-449a expression were found to have a poorer prognosis than those with high expression. Vascular invasion, increased serum carbohydrate antigen 19-9 level and low miR-449a were associated with poorer disease-free survival. miR-449a expression was lower in metastatic liver tumor compared to primary tumor. HDAC1 positivity was higher in patients with low miR-449a.

Conclusion

miR-449a level might be a prognostic indicator for colorectal cancer and miR-449a might regulate HDAC1 expression.



Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

PMID:31177123






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements